1. |
Aliberti S, Brambilla AM, Chalmers JD, et al. Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis. Respir Res, 2014, 15: 27.
|
2. |
Raghavan M, Kellum JA. Hydrocortisone infusion may improve survival in patients with severe community-acquired pneumonia. Critical Care, 2005, 9(6): E24-E24.
|
3. |
Wan YD, Sun TW, Liu ZQ, et al. Efficacy and safety of corticosteroids for community-acquired pneumonia: a systematic review and meta-analysis. Chest, 2016, 149(1): 209-219.
|
4. |
Shea BJ, Grimshaw JM, Wells GA, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol, 2007, 7: 10.
|
5. |
Lim W S, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax, 2009, 64(Suppl 3): iii1-iii55.
|
6. |
陶欢, 杨乐天, 平安, 等. 随机或非随机防治性研究系统评价的质量评价工具 AMSTAR 2 解读. 中国循证医学杂志, 2018(1): 101-108.
|
7. |
Moher D, Liberati A, Tetzlaff J, et al. 系统综述和荟萃分析优先报告的条目: PRISMA 声明. 李迅, 曹卉娟, 刘建平, 译. 中西医结合学报, 2009, 7(9): 889-896.
|
8. |
Bi J, Yang J, Wang Y, et al. Efficacy and safety of adjunctive corticosteroids therapy for severe community-acquired pneumonia in adults: an updated systematic review and meta-analysis. PLoS One, 2016, 11(11): e0165942.
|
9. |
Cheng M, Pan ZY, Yang J, et al. Corticosteroid therapy for severe community-acquired pneumonia: a meta-analysis. Respir Care, 2014, 59(4): 557-563.
|
10. |
Gorman SK, Slavik RS, Marin J. Corticosteroid treatment of severe community-acquired pneumonia. Ann Pharmacother, 2007, 41(7/8): 1233-1237.
|
11. |
Horita N, Otsuka T, Haranaga S, et al. Adjunctive systemic corticosteroids for hospitalized community-acquired pneumonia: systematic review and meta-analysis 2015 update. Sci Rep, 2015, 5: 14061.
|
12. |
Lamontagne F, Briel M, Guyatt GH, et al. Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials. J Crit Care, 2010, 25(3): 420-435.
|
13. |
Marti C, Grosgurin O, Harbarth SA, et al. Adjunctive corticotherapy for community acquired pneumonia: a systematic review and meta-analysis. PLoS One, 2015, 10(12): e0144032.
|
14. |
Nie W, Zhang Y, Cheng J, et al. Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis. PLoS One, 2012, 7(10): e47926.
|
15. |
Salluh JI, Povoa P, Soares MA, et al. The role of corticosteroids in severe community-acquired pneumonia: a systematic review. Crit Care, 2008, 12(3): R76.
|
16. |
Salluh JI, Shinotsuka CR, Soares M, et al. Cortisol levels and adrenal response in severe community-acquired pneumonia: a systematic review of the literature. J Crit Care, 2010, 25(3): 541.e1-541.e8.
|
17. |
Shafiq M, Mansoor MS, Khan AA, et al. Adjuvant steroid therapy in community-acquired pneumonia: a systematic review and meta-analysis. J HospMed, 2013, 8(2): 68-75.
|
18. |
Siemieniuk RA, Meade MO, Alonso-Coello P, et al. Corticosteroid therapy for patients hospitalized with community acquired pneumonia a systematic review and meta-analysis. Ann Intern Med, 2015, 163(7): 519-528.
|
19. |
Siempos II, Vardakas KZ, Kopterides P, et al. Adjunctive therapies for community-acquired pneumonia: a systematic review. J Antimicrob Chemother, 2008, 62(4): 661-668.
|
20. |
Wu WF, Fang Q, He GJ. Efficacy of corticosteroid treatment for severe community-acquired pneumonia: a meta-analysis. Am J Emerg Med, 2018, 36(2): 179-184.
|
21. |
田欣伦, 江梅, 孙雪峰, 等. 糖皮质激素治疗成人社区获得性肺炎适应证的荟萃分析. 中华结核和呼吸杂志, 2016, 39(4): 280-285.
|
22. |
王轲, 蒋丽娟, 戴聪, 等. 激素治疗老年重症社区获得性肺炎的 Meta 分析. 中华临床医师杂志: 电子版, 2014, 20(20): 3640-3645.
|
23. |
刘娥. 糖皮质激素对重症社区获得性肺炎治疗作用的循证医学证据. 沈阳: 中国医科大学, 2013.
|